The rising use of GLP-1 medications, such as Novo Nordisk’s Wegovy and Ozempic, for weight loss has driven up patients’ visits to their physicians, resulting in more frequent diagnoses of other health issues, Finimize reported Dec. 16.
Winston-Salem, N.C.-based Atrium Health Wake Forest Baptist has earned a certificate of need for a $25 million multispecialty outpatient surgical center at its eye institute, according to a Dec. 12 report from the Triad Business Journal.
Medtronic has partnered with the University of Miami Health System to perform the first-ever patient procedure ingestion using the PillCam Genius SB capsule endoscopy kit.
The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease.
The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease.